PRESS RELEASE published on 06/13/2025 at 08:30, 10 months 29 days ago Transgene to Participate in Upcoming Meetings with Biotech Industry Leaders Transgene to participate in upcoming meetings with biotech industry leaders to discuss positive clinical data on neoantigen cancer vaccine TG4050 and present innovative immunotherapies. Learn more at www.transgene.com Biotech Industry Clinical Data Transgene Immunothérapies Neoantigen Cancer Vaccine
PRESS RELEASE published on 06/13/2025 at 08:00, 10 months 29 days ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces purchase of 70,000 Ordinary Shares at prices ranging from 294.40p to 310.00p per share on 12 June 2025. Share capital details provided Share Repurchase Ordinary Shares Molten Ventures Plc Numis Securities LSE: GROW
PRESS RELEASE published on 06/13/2025 at 07:45, 10 months 29 days ago REALITES finalise la vente de l’Hôtel Lincoln, monument emblématique de Casablanca REALITES finalise la vente de l'Hôtel Lincoln, monument emblématique de Casablanca, marquant l'aboutissement d'un projet de réhabilitation patrimoniale et urbaine exemplaire REALITES Rehabilitation Casablanca Hôtel Lincoln Patrimonial
PRESS RELEASE published on 06/13/2025 at 07:45, 10 months 29 days ago REALITES finalise la vente de l’Hôtel Lincoln, monument emblématique de Casablanca REALITES finalise la vente de l'Hôtel Lincoln, monument emblématique de Casablanca, marquant l'aboutissement d'un projet de réhabilitation patrimoniale et urbaine REALITES Rehabilitation Casablanca Hôtel Lincoln Patrimonial
PRESS RELEASE published on 06/13/2025 at 07:30, 10 months 29 days ago Inside Information / Other news releases MaaT Pharma presents updated positive data for Xervyteg® in treating acute Graft-versus-Host Disease at EHA Congress, validating high efficacy observed in pivotal ARES study MaaT Pharma Acute Graft-versus-Host Disease EMA Approval Xervyteg EAP Data
PRESS RELEASE published on 06/13/2025 at 07:30, 10 months 29 days ago Informations privilégiées / Autres communiqués MaaT Pharma présente des données actualisées positives pour Xervyteg® lors du Congrès de l’EHA confirmant une forte efficacité observée dans l’étude pivotale ARES dans la maladie aiguë du greffon contre l’hôte Thérapie MaaT Pharma AGvH Xervyteg EHA
PRESS RELEASE published on 06/13/2025 at 07:00, 10 months 29 days ago Informations privilégiées / Autres communiqués Signature d’une promesse de vente pour l'acquisition d'un immeuble prestigieux au 88 rue de Rivoli à Paris par Immobilière Dassault SA Acquisition Paris Immeuble Immobilière Dassault Prestige
PRESS RELEASE published on 06/13/2025 at 07:00, 10 months 29 days ago Inside Information / Other news releases Innate Pharma highlights preclinical antitumor activity of IPH6501 in DLBCL and FL at the 2025 EHA Congress, presenting potent efficacy in in vitro and in vivo models with R-CHOP combination Preclinical Data EHA Congress Innate Pharma Antitumor Activity IPH6501
PRESS RELEASE published on 06/13/2025 at 06:57, 10 months 29 days ago Adjustment of the Conversion Price for the convertible bond of LEG Immobilien SE in the amount of EUR 400 million due on September 1, 2025 (ISIN DE000A2GSDH2) LEG Immobilien SE adjusts Conversion Price for EUR 400 million convertible bond due on Sep 1, 2025, following dividend payments. Conversion Price now EUR 112.9577 Financial Year 2024 Convertible Bond Conversion Price LEG Immobilien SE Dividend Adjustment
PRESS RELEASE published on 06/13/2025 at 06:30, 10 months 29 days ago Fusion du Helvetica Swiss Commercial Fund et du Helvetica Swiss Opportunity Fund: annonce du rapport d’échange Fusion des fonds immobiliers Helvetica Swiss Commercial Fund et Helvetica Swiss Opportunity Fund, gérés par Helvetica Property Investors AG, fixée au 20 juin 2025. Rapport d'échange et détails de la fusion SIX Swiss Exchange Fusions & Acquisitions Fonds Helvetica Property Rapport D'Échange
Published on 05/12/2026 at 21:55, 2 hours 3 minutes ago UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/12/2026 at 21:42, 2 hours 16 minutes ago Kidoz Inc. to Present at Planet MicroCap Las Vegas 2026
Published on 05/12/2026 at 14:30, 9 hours 28 minutes ago Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement
Published on 05/12/2026 at 14:30, 9 hours 28 minutes ago ACCESS Newswire Reports First Quarter 2026 Results
Published on 05/12/2026 at 23:47, 10 minutes ago Nebius welcomes Clarifai’s core team and licenses inference IP to strengthen Nebius Token Factory
Published on 05/12/2026 at 22:25, 1 hour 32 minutes ago Evotec SE Successfully Placed €116.1 Million Convertible Bonds
Published on 05/12/2026 at 20:21, 3 hours 36 minutes ago Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri
Published on 05/12/2026 at 19:35, 4 hours 22 minutes ago AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results
Published on 05/12/2026 at 19:35, 4 hours 23 minutes ago 2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy
Published on 05/12/2026 at 18:15, 5 hours 43 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026
Published on 05/12/2026 at 18:15, 5 hours 43 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 5 hours 48 minutes ago imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026
Published on 05/12/2026 at 18:10, 5 hours 48 minutes ago imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026
Published on 05/12/2026 at 17:50, 6 hours 8 minutes ago Damartex fait évoluer sa gouvernance et engage une réflexion stratégique autour de ses activités